Beyond “Safe and Effective”: The Role of the Federal Government in Supporting and Disseminating Comparative-Effectiveness Research

DSpace/Manakin Repository

Beyond “Safe and Effective”: The Role of the Federal Government in Supporting and Disseminating Comparative-Effectiveness Research

Show simple item record

dc.contributor.advisor Peter Hutt en_US
dc.contributor.author Francis, Margaret
dc.date.accessioned 2012-07-06T22:07:29Z
dc.date.issued 2011
dc.identifier.citation Margaret Francis, Beyond “Safe and Effective”: The Role of the Federal Government in Supporting and Disseminating Comparative-Effectiveness Research (May 2011). en_US
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8965628
dc.description.abstract Over the past century, medical advancements have resulted in tremendous health gains for Americans. Although the federal government has played a prominent role in ensuring that new treatments are safe and effective, questions about which medical treatments work best under which circumstances have largely remained unanswered. Thus, the federal government’s recent major investments in comparative-effectiveness research have potential to play a significant role helping both patients and health care providers navigate the vast array of available treatment options, as well as to improve the quality, efficiency, and delivery health care system-wide. Yet, the controversial nature of the government’s foray into comparative-effectiveness research also suggests that the path toward realizing these goals may be treacherous. This paper describes the rationales for federal support of comparative-effectiveness research and potential models for that involvement, analyzes the federal government’s recent investments in the research, and concludes with predictions about the probable outcomes of these investments. While increased federal support for comparative-effectiveness research is unlikely to achieve all of the benefits anticipated by its supporters, it is a crucial step toward ensuring that Americans are able to take full advantage of the benefits of medical innovation. en_US
dash.license LAA
dc.subject.other Food and Drug Law en_US
dc.title Beyond “Safe and Effective”: The Role of the Federal Government in Supporting and Disseminating Comparative-Effectiveness Research en_US
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-07-06T22:07:29Z

Files in this item

Files Size Format View
Francis, Margaret H..pdf 387.9Kb PDF View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters